Home › Funds › Millennium Management › OCUL
Millennium Management position in OCUL
OCULAR THERAPEUTIX INC · Health Care
Latest position (Q1 2026)34.01K sh
Reported value held$288.03K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 281.28K | $2.81M | New |
| Q4 2021 | 292.19K | $2.04M | Add |
| Q1 2022 | 735.73K | $3.64M | Add |
| Q2 2022 | 349.20K | $1.40M | Reduce |
| Q3 2022 | 201.07K | $834.00K | Reduce |
| Q4 2022 | 77.32K | $217 | Reduce |
| Q1 2023 | 1.04M | $5.46K | Add |
| Q2 2023 | 2.40M | $12.37M | Add |
| Q3 2023 | 685.74K | $2.15M | Reduce |
| Q4 2023 | 775.17K | $3.46M | Add |
| Q1 2024 | 169.33K | $1.54M | Reduce |
| Q4 2024 | 447.24K | $3.82M | New |
| Q2 2025 | 119.15K | $1.11M | New |
| Q3 2025 | 3.86M | $45.07M | Add |
| Q4 2025 | 3.28M | $39.79M | Reduce |
| Q1 2026 | 34.01K | $288.03K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding OCUL
- Fidelity Management & Research (FMR) 32.84M sh · $322.53M · Q2 2026
- BlackRock Inc 19.38M sh · $190.28M · Q2 2026
- Vanguard Group 11.58M sh · $140.52M · Q4 2025
- Geode Capital Management 5.02M sh · $49.32M · Q2 2026
- Point72 Asset Management 3.29M sh · $32.33M · Q2 2026
- Balyasny Asset Management 3.25M sh · $31.87M · Q2 2026
- Northern Trust Corp 1.80M sh · $17.67M · Q2 2026
- Goldman Sachs Group 1.76M sh · $17.30M · Q2 2026
- UBS Group AG 1.55M sh · $15.23M · Q2 2026
- Charles Schwab Investment Management 1.53M sh · $15.06M · Q2 2026
- Invesco Ltd 1.34M sh · $13.20M · Q2 2026
- Two Sigma Investments 1.22M sh · $11.97M · Q2 2026